About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT04524481

Osteoporosis and Haemophilia

The aim of this study is to evaluate the prevalence of osteoporosis in adult patients with haemophilia.

Lead sponsor: PD Dr. Andreas Strauß•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Andreas Strauß, PD Dr.

CONTACT

004922828714176 [email protected]

Sponsors

Lead Sponsor

PD Dr. Andreas Strauß

Collaborators

Bayer

The aim of this study is to evaluate the prevalence of osteoporosis in adult patients with haemophilia. Subsequently, the ascertained prevalence of osteoporosis in patients with haemophilia will be compared to the latest published data of osteoporosis in Germany. Furthermore, the impact of severity of haemophilia, comorbidities as well as the role of both physical activity and individual joint condition as influencing factors on the presence of osteoporosis will be analysed by this study.

Age

18 - No limit years

Sex

MALE

Healthy Volunteers

No

Inclusion Criteria

•Adult patients (≥ 18 years of age) suffering from mild (FVIII or IX \>5 %), moderate (FVIII or IX 1-5 %) or severe (FVIII or IX \<1 %) haemophilia A or B
•Submitted written consent to participate in the study

Exclusion Criteria

•Patients suffering from other bleeding diseases
•PWH without written consent
•PWH \< 18 years of age
•Secondary osteoporosis

Related studies

The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures

NCT07027306 · Osteoporotic Fractures, Osteoporosis

RECRUITINGPhase 3

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

NCT06716814 · Haemophilia A (Moderate or Severe)

RECRUITINGPhase 4

Combined Anabolic Therapy

NCT06558188 · Osteoporosis, Postmenopausal, Osteoporosis

RECRUITINGPhase 4

GLP-1R Actions on Muscle and the Skeleton

NCT07154719 · Musculoskeletal Abnormalities, Obesity, and more

A Prospective Observational Study of Artificial Intelligence Morphometric Evaluation of Vertebral Fractures

NCT06449742 · Vertebral Fracture, Osteoporosis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 29, 2021Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment250

Start dateAug 2020

Last updatedOct 29, 2021

Condition

Osteoporosis Haemophilia Bone Mass

Locations shown

University Hospital of Bonn

Bonn, Northrhine Westfalia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 29, 2021Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions